scholarly article | Q13442814 |
P356 | DOI | 10.1590/S0102-86502013000700005 |
P8608 | Fatcat ID | release_5l3rrd2q3nczfjeavyy6tfyt6i |
P698 | PubMed publication ID | 23842931 |
P2093 | author name string | César Tadeu Spadella | |
Lucas Langoni Cassettari | |||
Amanda Natália Lucchesi | |||
Natália Tavares de Freitas | |||
Sílvio Fernando Guideti Marques | |||
P2860 | cites work | The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis | Q28345942 |
Leptin and the regulation of body weight in mammals | Q29615976 | ||
Etiopathogenesis of nonalcoholic steatohepatitis | Q34215140 | ||
Lipid peroxidation in diabetes mellitus | Q34384380 | ||
Influence of body fat distribution on free fatty acid metabolism in obesity | Q34570120 | ||
The metabolic abnormalities associated with non-alcoholic fatty liver disease | Q34983519 | ||
Antioxidants, oxidative damage and oxygen deprivation stress: a review | Q35037504 | ||
The liver in obesity and type 2 diabetes mellitus | Q35040091 | ||
Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease | Q35792208 | ||
Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. | Q36039854 | ||
Pathogenesis and management issues for non-alcoholic fatty liver disease | Q36179902 | ||
The role of oxidative stress in diabetic complications | Q36210199 | ||
Recent concepts in non-alcoholic fatty liver disease | Q36234172 | ||
Advanced glycation end products and diabetic nephropathy. | Q36310456 | ||
Proposed mechanisms for the induction of insulin resistance by oxidative stress | Q36342638 | ||
AGE, RAGE, and ROS in diabetic nephropathy. | Q36785561 | ||
Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. | Q36826243 | ||
Present and future therapeutic strategies in non-alcoholic fatty liver disease | Q36936358 | ||
Pathology of nonalcoholic fatty liver disease | Q36977000 | ||
Oxidative damage to extracellular matrix and its role in human pathologies. | Q37142535 | ||
Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. | Q38296226 | ||
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities | Q43552270 | ||
Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease | Q43879331 | ||
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway | Q44967749 | ||
Oxidative damage to nuclear DNA in streptozotocin-diabetic rat liver | Q46667352 | ||
P433 | issue | 7 | |
P921 | main subject | chronic liver disease | Q5113984 |
P304 | page(s) | 502-508 | |
P577 | publication date | 2013-07-01 | |
P1433 | published in | Acta Cirurgica Brasileira | Q15753877 |
P1476 | title | Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease. | |
P478 | volume | 28 |
Q43177845 | Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans. |
Q47370468 | Anti-hypoglycemic and hepatocyte-protective effects of hyperoside from Zanthoxylum bungeanum leaves in mice with high-carbohydrate/high-fat diet and alloxan-induced diabetes |
Q37334432 | Antidiabetic and antioxidant effects of Croton lobatus L. in alloxan-induced diabetic rats |
Q51305000 | Antidiabetic mechanism of Coptis chinensis polysaccharide through its antioxidant property involving the JNK pathway. |
Q64075082 | Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis |
Q41841136 | Effects of berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in vivo |
Q91785438 | Efficacy of Ginger (Zingiber officinale) in Ameliorating Streptozotocin-Induced Diabetic Liver Injury in Rats: Histological and Biochemical Studies |
Q64093615 | Hepatoprotective Potential of against STZ-Induced Diabetic Liver Damage in Wistar Rats by Inhibiting Cytokines and the Apoptosis Pathway |
Q38575779 | Markers of Oxidative Stress during Diabetes Mellitus. |
Q35544336 | Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase |
Q35484180 | Piperine, a natural bioenhancer, nullifies the antidiabetic and antioxidant activities of curcumin in streptozotocin-diabetic rats |
Q33886918 | Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis |
Q92635526 | The Underlying Mechanisms of Curcumin Inhibition of Hyperglycemia and Hyperlipidemia in Rats Fed a High-Fat Diet Combined With STZ Treatment |
Q46873961 | The protection of Rhein lysinate to liver in diabetic mice induced by high-fat diet and streptozotocin |
Q36741947 | Transcriptome Profiles Using Next-Generation Sequencing Reveal Liver Changes in the Early Stage of Diabetes in Tree Shrew (Tupaia belangeri chinensis) |
Q42186198 | Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients |
Q42138529 | Vitis vinifera (Muscat Variety) Seed Ethanolic Extract Preserves Activity Levels of Enzymes and Histology of the Liver in Adult Male Rats with Diabetes |
Search more.